ATE328073T1 - Ehrlichia canis protein - Google Patents

Ehrlichia canis protein

Info

Publication number
ATE328073T1
ATE328073T1 AT99942504T AT99942504T ATE328073T1 AT E328073 T1 ATE328073 T1 AT E328073T1 AT 99942504 T AT99942504 T AT 99942504T AT 99942504 T AT99942504 T AT 99942504T AT E328073 T1 ATE328073 T1 AT E328073T1
Authority
AT
Austria
Prior art keywords
kda protein
canis
recombinant
ehrlichia
ehrlichia canis
Prior art date
Application number
AT99942504T
Other languages
English (en)
Inventor
David H Walker
Xu-Jie Yu
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE328073T1 publication Critical patent/ATE328073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
AT99942504T 1998-08-27 1999-08-27 Ehrlichia canis protein ATE328073T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/141,047 US6043085A (en) 1998-08-27 1998-08-27 Ehrlichia canis 120-kDa immunodominant antigenic protein and gene

Publications (1)

Publication Number Publication Date
ATE328073T1 true ATE328073T1 (de) 2006-06-15

Family

ID=22493934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942504T ATE328073T1 (de) 1998-08-27 1999-08-27 Ehrlichia canis protein

Country Status (17)

Country Link
US (1) US6043085A (de)
EP (1) EP1108014B1 (de)
JP (1) JP4550998B2 (de)
KR (1) KR100652469B1 (de)
CN (1) CN1281747C (de)
AT (1) ATE328073T1 (de)
AU (1) AU764853B2 (de)
BR (1) BR9913652B1 (de)
CA (1) CA2340462A1 (de)
DE (1) DE69931639D1 (de)
IL (2) IL141613A0 (de)
MX (1) MXPA01002042A (de)
NZ (1) NZ510103A (de)
RU (1) RU2232814C2 (de)
TW (1) TW557326B (de)
WO (1) WO2000012688A1 (de)
ZA (1) ZA200101440B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115840A1 (en) * 1998-11-30 2002-08-22 Walker David H. Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof
US6392023B1 (en) * 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US7335754B2 (en) * 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
US6355777B1 (en) * 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
US20020064531A1 (en) * 2000-05-01 2002-05-30 Walker David H. Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family
ES2293057T3 (es) * 2002-11-04 2008-03-16 Research Development Foundation Antigenos p153 y p156 para la inmunodiagnosis de ehrliquiosis canina y humana y uso de los mismos.
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
WO2006107924A2 (en) * 2005-04-04 2006-10-12 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infected from vaccinated animals)
US7842474B2 (en) * 2005-04-04 2010-11-30 Idexx Laboratories, Inc. Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
WO2009034575A1 (en) 2007-09-11 2009-03-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Attenuated ehrlichiosis vaccine
EP2203469A4 (de) * 2007-09-21 2011-08-24 Idexx Lab Inc Verfahren und zusammensetzungen zum nachweis von ehrlichia chaffeensis (p120)
EP2231696A4 (de) * 2007-09-21 2012-02-15 Idexx Lab Inc Verfahren und zusammensetzungen zum nachweis von ehrlichia chaffeensis (vlpt)
EP2045816A1 (de) * 2007-10-01 2009-04-08 Paul Scherrer Institut Schnelles Auslesungsverfahren und Schaltkondensator-Arrayschaltung zur Wellenform-Digitalisierung
CZ2007716A3 (cs) 2007-10-15 2009-04-29 Elmarco S. R. O. Zpusob výroby nanovláken
EP2215477B1 (de) * 2007-10-31 2019-01-16 IDEXX Laboratories Inc Ehrlichia canis-diva (unterscheidung von infizierten und geimpften tieren)
KR101010432B1 (ko) * 2008-08-30 2011-01-21 이영수 여과기
DK2424880T3 (en) * 2009-04-28 2016-10-24 Res Dev Foundation Immunoreactive Ehrlichia p120 / p140 epitopes, and uses thereof
KR101892182B1 (ko) * 2009-11-20 2018-08-24 아박시스, 인크. 에를리키아 항체의 검출을 위한 펩티드, 장치 및 방법
BR112012033751B1 (pt) * 2010-07-02 2021-06-01 Intervet International B.V. Composição de vacina e processo para produzir a composição de vacina
CN105051541B (zh) 2012-10-11 2017-07-04 爱贝斯股份有限公司 用于检测埃里希体属抗体的肽、装置和方法
US9442112B2 (en) 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
WO2020023950A1 (en) * 2018-07-27 2020-01-30 Research Development Foundation Chimeric immunogenic polypeptides
CN114514238A (zh) * 2019-07-12 2022-05-17 研究发展基金会 埃立克体疫苗和免疫原性组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015691A (en) * 1996-05-31 2000-01-18 Research Development Foundation Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis

Also Published As

Publication number Publication date
BR9913652B1 (pt) 2014-02-18
NZ510103A (en) 2004-10-29
TW557326B (en) 2003-10-11
IL141613A (en) 2010-05-31
DE69931639D1 (en) 2006-07-06
ZA200101440B (en) 2002-01-30
AU764853B2 (en) 2003-09-04
JP4550998B2 (ja) 2010-09-22
KR20010072997A (ko) 2001-07-31
CN1321190A (zh) 2001-11-07
EP1108014B1 (de) 2006-05-31
CN1281747C (zh) 2006-10-25
EP1108014A1 (de) 2001-06-20
MXPA01002042A (es) 2002-06-21
JP2002523087A (ja) 2002-07-30
AU5586499A (en) 2000-03-21
CA2340462A1 (en) 2000-03-09
BR9913652A (pt) 2001-06-05
US6043085A (en) 2000-03-28
EP1108014A4 (de) 2004-12-15
RU2232814C2 (ru) 2004-07-20
IL141613A0 (en) 2002-03-10
WO2000012688A1 (en) 2000-03-09
KR100652469B1 (ko) 2006-12-01

Similar Documents

Publication Publication Date Title
ATE328073T1 (de) Ehrlichia canis protein
AR062019A1 (es) Gen de bacillus thuringiensis con actividad contra lepidopteros
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
DE69938302D1 (de) Neisseria meningitidis antigene und zusammenstellungen
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DE60144145D1 (de) Subtilisin-variante
BR9906927A (pt) Proteìnas de neisseria meningitidis
DK0652287T3 (da) Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom
DE60228136D1 (de) Cytokin-proteinfamilie
ATE323164T1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
DE60139959D1 (de) Nukleinsäureadjuvantien
SE9602822D0 (sv) New receptor
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
DK0778894T3 (da) Vaccine mod infektiös felin peritonitis
ATE344802T1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
BR0010222A (pt) Vetores de expressão viral
ATE414905T1 (de) Diabetesmodell
ATE298348T1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
MXPA01007582A (es) Control de infeccion por virus utilizando proteinas asociadas de replicacion, composiciones y metodos de uso.
EP0949333A4 (de) Mutierte antigene des masernvirus und die dafür kodierenden gene.
TH62970A (th) วัคซีนไวรัสโรคเบอร์ซาอักเสบติดต่อชนิดบรอดสเปคตรัม (broad spectrum)
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren
TH54286A (th) สายพันธุ์ไคเมอริค IBDV ซีโรไทพ์ (serotype chimeric IBDV strains)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties